Healthcare Press

Trial shows mistletoe extract does not increase survival in advanced pancreatic cancer

  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 45 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 38%
  • Publisher: 51%

Medicine Research News News

Medicine Research,Health Research News,Health Research

The MISTRAL study, involving 290 patients with advanced pancreatic cancer, has investigated whether treatment with mistletoe extract (ME) in addition to standard treatment could help patients live longer. The result is that the treatment did not make any difference compared to placebo in how long the patients lived.

Trial shows mistletoe extract does not increase survival in advanced pancreatic cancer retrieved 31 May 2024 from https://medicalxpress.com/news/2024-05-trial-mistletoe-survival-advanced-pancreatic.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.May 8, 2023Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Clinical trial shows CRISPR gene editing has exciting potential to treat a rare form of blindnessA recent study published in The New England Journal of Medicine investigated the potential use of gene editing to correct a congenital retinal degeneration called CEP290 that causes early-onset vision loss.
Source: NewsMedical - 🏆 19. / 71 Read more »